InsidersTradesSigma
Track the MDxHealth SA share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €43.9m. The latest transaction was disclosed on 17 August 2026 (Acquisition). Among the most active insiders: MVM Partners, LLC. All data is free.
Analysts rate MDxHealth SA Buy (bullish), based on 5 analysts. Average price target: US$2.20.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
MDxHealth SA is a company focused on developing diagnostic tests for cancer, emphasizing personalized medicine. It is listed on NASDAQ.